This study could pave the way for developing targeted therapeutic strategies by regulating the miR-182-5p-Sesn2 axis to promote the function of SCs and improve regeneration in the context of muscular dystrophy, such as DMD. The gene discussed is SESN2; the disease is muscular dystrophy.